Diamedica Therapeutics Inc.

(DMA:CX2)

By |

Profile

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. It is principally engaged in the business activity of developing treatments for unmet clinical need or where no therapies are available with a primary focus on neurological and kidney diseases. Its pipeline products include DM300, DM199, and others. Majority of the company's operations are carried out in the United States of America.

Contact Information

Website: www.diamedica.com
Email: info@diamedica.com
Main Phone: +1 763 496-5454
Address: c/o DiaMedica USA Inc.
Address 2: Two Carlson Parkway, Suite 165
State: MN
City / Town: Minneapolis
Country: USA
Postal Code: 55447

Issuer Information

Exchange: CDX
CEO: Rick Pauls
Employees: 11
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.25 1.25 1.25 1.25
Low Target Price Estimate 1.25 1.25 1.25 1.25
Mean Target Price Estimate 1.25 1.25 1.25 1.25
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 2.3